There is no excerpt because this is a protected post.
What is new in oncology surgery? Read our oncology surgery blog and learn more about the advancements in surgery for oncologic diseases.
Recent studies have shown new possible applications for Ki67. Huh et al. showed that low Ki67 levels in healthy breast tissue correlated with a lesser lifetime chance of breast cancer. Another study by Arnedos and colleagues concluded that palbociclib was able to invoke a significant Ki67-level drop. After a decade of Ki67-controversies, these results put the marker back in the spotlight.